SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Fund Management Regulatory News (JUP)

Share Price Information for Jupiter Fund Management (JUP)

Share Price is delayed by 15 minutes
Get Live Data
176.00    0.00 (0.00%)
Bid:
176.60
Ask:
177.00
Spread: 0.40 (0.227%)
Market Cap: £883.48m
JUP Live PriceLast checked at - London Stock Exchange

Intraday Jupiter Fund Management Share Chart

Admission of Consideration Shares

2 Jul 2020 08:05

RNS Number : 7802R
Jupiter Fund Management PLC
02 July 2020
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

Β 

Β 

2 July 2020

Β 

Jupiter Fund Management plc ("Jupiter" or the "Company")

Admission of the Consideration Shares to listing on the Official List and to trading on the London Stock Exchange and appointment of Christopher Parkin as a Non-Executive Director

Β 

Further to its announcement on 17 February 2020 in relation to the proposed acquisition of Merian Global Investors Limited ("Merian") (the "Acquisition"), its announcement on 21 May 2020 in relation to the approval of the Acquisition by Jupiter shareholders and its announcement on 1 July 2020 in relation to the completion of the Acquisition, Jupiter is pleased to announce that 95,360,825 new ordinary shares (theΒ "Consideration Shares") were admitted to listing on the premium listing segment of the Official List of the Financial Conduct Authority and were admitted to trading on the London Stock Exchange's main market for listed securities ("Admission") at 8:00 a.m. today.Β The Consideration Shares have been allotted to the sellers of Merian as consideration for the Acquisition, with completion of the Acquisition having occurred on 1 July 2020.

Jupiter confirms that, immediately following Admission, the total number of ordinary shares in issue was 553,060,741.Β Each ordinary share carries the right to one vote and no ordinary shares are held in treasury, accordingly the total voting rights in the Company are 553,060,741.Β This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change in their interest in, the Company under the Disclosure Guidance and Transparency Rules.

Jupiter is also pleased to confirm the appointment of Christopher Parkin as a non-executive director with immediate effect. Christopher has been nominated as a non-executive director pursuant to Mintaka LP's and TA Associates Management LP's rights under the relationship agreement entered into between them and Jupiter in connection with the Acquisition.

The Company confirms that there is no information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Chris Parkin's appointment.

Β 

Enquiries

Β 

Jupiter Fund Management plc +44 (0) 20 3817 1000

Andrew Formica, Chief Executive

Wayne Mepham, Chief Financial Officer

Alex Sargent (Investor Relations) +44 (0) 20 3817 1534

Despina Constantinides (Media Relations) +44 (0) 20 3817 1278

Β 

Fenchurch Advisory Partners LLP +44 (0) 20 7382 2222

(Lead Financial Advisor)

Vincent Bounie

Malik Karim

Philip Evans

Β 

J. P. Morgan Cazenove +44 (0) 20 7742 4000

(Joint Financial Advisor and Joint Corporate Broker)

Edward Squire

Andrew Stockdale

Β 

Numis +44 (0) 20 7260 1000

(Joint Corporate Broker)

Charles Farquhar

Stephen Westgate

Β 

Powerscourt +44 (0) 20 7250 1446

(Financial Communications Advisor to Jupiter)

Justin Griffiths

Victoria Heslop

Β 

Jupiter Fund Management plc

LEI Number: 5493003DJ1G01IMQ7S28

Β 

Important Notice

The release, publication or distribution of this announcement in jurisdictions other than the United Kingdom may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom should inform themselves about, and observe, any applicable requirements. The information disclosed in this announcement may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

This announcement is not intended to, and does not constitute, or form part of, an offer to sell or an invitation to purchase or subscribe for any securities or a solicitation of any vote or approval in any jurisdiction. This announcement does not constitute a prospectus or a prospectus equivalent document.

Β 

Disclaimer

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), and which is authorised in the United Kingdom by the Prudential Regulation Authority (the "PRA") and regulated by the PRA and the FCA, is acting as financial adviser, sponsor and joint corporate broker exclusively for Jupiter and no one else in connection with the Acquisition and will not regard any other person as its client in relation to the Acquisition and will not be responsible to anyone other than Jupiter for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to the Acquisition or any other matter or arrangement referred to herein.

Fenchurch Advisory Partners LLP ("Fenchurch"), which is authorised and regulated by the FCA in the UK, is acting as lead financial adviser exclusively for Jupiter and no one else in connection with the Acquisition and will not regard any other person as its client in relation to the Acquisition and will not be responsible to anyone other than Jupiter for providing the protections afforded to clients of Fenchurch or its affiliates, nor for providing advice in relation to the Acquisition or any other matter or arrangement referred to herein.

Numis Securities Limited ("Numis"), which is authorised and regulated by the FCA the United Kingdom, is acting exclusively as corporate broker for Jupiter and no one else in connection with the Acquisition and will not regard any other person as its client in relation to the Acquisition and will not be responsible to anyone other than Jupiter for providing the protections afforded to clients of Numis or its affiliates nor for providing any advice in relation to the Acquisition and or any other matter or arrangement referred to herein.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCUAAWRRNUBRAR
Date   Source Headline
15th Jun 20262:45 pmRNSTransaction in Own Shares
10th Jun 20263:15 pmRNSTransaction in Own Shares - Replacement
9th Jun 202612:15 pmRNSHolding(s) in Company
8th Jun 20264:00 pmRNSTransaction in Own Shares
2nd Jun 20265:19 pmRNSHolding(s) in Company
1st Jun 202611:00 amRNSTransaction in Own Shares
29th May 20265:15 pmRNSTotal Voting Rights
28th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20263:45 pmRNSTransaction in Own Shares
18th May 20263:30 pmRNSTransaction in Own Shares
11th May 20264:57 pmRNSTransaction in Own Shares
8th May 20264:00 pmRNSHolding(s) in Company
7th May 20263:30 pmRNSHolding(s) in Company
7th May 20261:00 pmRNSResult of AGM
5th May 20264:00 pmRNSTransaction in Own Shares
5th May 20263:00 pmRNSHolding(s) in Company
5th May 20262:45 pmRNSHolding(s) in Company
30th Apr 20265:00 pmRNSTotal Voting Rights
30th Apr 20262:45 pmRNSHolding(s) in Company
28th Apr 202612:45 pmRNSHolding(s) in Company
27th Apr 20264:02 pmRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTrading Update and Notice of Results
20th Apr 202612:20 pmRNSTransaction in Own Shares
14th Apr 20262:00 pmRNSDirector/PDMR Shareholding
13th Apr 20261:00 pmRNSTransaction in Own Shares
8th Apr 20267:00 amRNSShare Buyback Programme
1st Apr 20263:00 pmRNSDirector/PDMR Shareholding
30th Mar 20263:00 pmRNSDirector/PDMR Shareholding
27th Mar 20263:30 pmRNSDirector/PDMR Shareholding
26th Mar 202612:12 pmRNSHolding(s) in Company
25th Mar 20264:51 pmRNSHolding(s) in Company
24th Mar 20262:03 pmRNSHolding(s) in Company
24th Mar 20262:00 pmRNSAnnual Report and Accounts and Notice of AGM
18th Mar 20262:00 pmRNSHolding(s) in Company
4th Mar 202612:30 pmRNSHolding(s) in Company
4th Mar 202612:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:45 pmRNSDirector/PDMR Shareholding
27th Feb 20263:30 pmRNSDirector Shareholding
27th Feb 20263:15 pmRNSTotal Voting Rights
26th Feb 20265:00 pmRNSCancellation of Treasury Shares
26th Feb 20267:00 amRNSAnnual Financial Report
9th Feb 20263:45 pmRNSHolding(s) in Company
6th Feb 20263:26 pmRNSStandard form for notification of major holdings
5th Feb 20262:42 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSHolding(s) in Company
2nd Feb 20261:30 pmRNSHolding(s) in Company
2nd Feb 20269:53 amRNSCompletion of Acquisition of CCLA
22nd Jan 20262:04 pmRNSHolding(s) in Company
7th Jan 20263:15 pmRNSHolding(s) in Company
31st Dec 202511:00 amRNSEntry into Forward Transaction for EBT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.